Trade CRBU stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Caribou Biosciences, Inc. (CRBU) is trading at US$0.47, up 1.12% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$177.96M. Over the past 52 weeks, CRBU has traded between US$0.44 and US$3.54. On Syfe you can trade CRBU with $0 commission and add it to your watchlist.
| Previous close | US$0.46 |
|---|---|
| Market cap | US$177.96M |
| 52-week range | US$0.44 – US$3.54 |
| Volume | 2.94M |
| Exchange | US |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Year: 2021
Caribou Biosciences, Inc. (CRBU) stock is trading at US$0.47, +1.12% from the previous close of US$0.46.
The market cap for Caribou Biosciences, Inc. (CRBU) stock is approximately US$177.96M.
The 52-week high for Caribou Biosciences, Inc. (CRBU) stock is US$3.54.
The 52-week low for Caribou Biosciences, Inc. (CRBU) stock is US$0.44.
Caribou Biosciences, Inc. (CRBU) does not currently pay a dividend.
Stay on top of CRBU
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
